Keyphrases
Comorbidity
100%
Disease Activity
100%
Multiple Sclerosis
100%
Disability Worsening
80%
Comorbid Conditions
60%
Confidence Interval
60%
Hazard Ratio
60%
Dyslipidemia
40%
Clinical Outcomes
40%
Clinical Trials
40%
Migraine
40%
Hypertension
20%
Adverse Events
20%
Medical History
20%
Disease Outcome
20%
Type 1 Diabetes Mellitus (T1DM)
20%
Disease-modifying Therapy
20%
Anxiety-depression
20%
Length of Follow-up
20%
Comorbidity Burden
20%
Anxiety Disorders
20%
MRI Activity
20%
Clinical Relapse
20%
Multivariable Cox Regression
20%
Concomitant Medications
20%
Glatiramer Acetate
20%
Large Trials
20%
MRI Outcomes
20%
Trial Population
20%
Interferon beta-1a
20%
Medication Events
20%
Clinical Trial Participant
20%
Medicine and Dentistry
Disease Activity
100%
Multiple Sclerosis
100%
Comorbidity
100%
Clinical Trial
66%
Hazard Ratio
50%
Magnetic Resonance Imaging
33%
Dyslipidemia
33%
Migraine
33%
Prevalence
16%
Adverse Event
16%
Medical History
16%
Proportional Hazards Model
16%
Disease Modifying Therapy
16%
Diabetes Mellitus
16%
Glatiramer
16%
Beta1a Interferon
16%
Diseases
16%
Anxiety Disorder
16%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
100%
Disease Activity
100%
Comorbidity
100%
Clinical Trial
66%
Dyslipidemia
33%
Migraine
33%
Diseases
33%
Adverse Event
16%
Medical History
16%
Prevalence
16%
Diabetes Mellitus
16%
Anxiety Disorder
16%
Glatiramer
16%
Beta1a Interferon
16%
Immunology and Microbiology
Multiple Sclerosis
100%
Comorbidity
100%
Magnetic Resonance Imaging
33%
Prevalence
16%
Glatiramer Acetate
16%
Interferon Beta 1a
16%
Food Science
Magnetic Resonance Imaging
100%